Persistent Platelet-Monocyte CrossTalk Underlies Failure to Resolve Inflammation and Symptoms in ME/CFS
Fördersumme: € 35.860
ME/CFS Biobank Austria
Dauer: 18 Monate, Fördersumme: € 100.000
Engineering synthetic enhancers and gene circuits to understand and overcome cancer therapy resistance
Dauer: 48 Monate, Fördersumme: € 899.099
Designing synthetic antigen-presenting cells to determine the 3D nanoenvironment of T-cell antigen recognition
Dauer: 48 Monate, Fördersumme: € 897.677
LymphoidStructureMiner: AI-based exploration of the immunological contexture of lymphoid structures in translational research
Dauer: 24 Monate, Fördersumme: € 480.236
Innate immune reprogramming to overcome therapy resistance in high-risk colorectal cancer
Dauer: 48 Monate, Fördersumme: € 800.000